Suramin and Paclitaxel in Treating Women With Stage IIIB-IV Breast Cancer
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
This phase I/II trial studies the best dose of suramin when given together with paclitaxel in
treating women with stage IIIB-IV breast cancer. Drugs used in chemotherapy use different
ways to stop tumor cells from dividing so they stop growing or die. Suramin may increase the
effectiveness of paclitaxel by making tumor cells more sensitive to the drug.